Akin Gump Strauss Hauer & Feld LLP published an analysis for drug developers regarding PDUFA VIII and proposed commitments emphasizing data modernization, expanded use of real-world evidence, enhanced review timelines for certain applications, and greater agency-industry engagement.

Akin is a global law firm with more than 1,100 lawyers and advisors who pride themselves on dedication to their clients and their communities. With offices worldwide, we are renowned for numerous market-leading practices; our strengths in complex transactions and restructurings, high-stakes litigation, and public policy and regulatory matters; and our unyielding pro bono commitment. We partner with clients from both established industries and cutting-edge markets to deliver creative solutions to business-critical issues, helping them seize opportunities and anticipate challenges. Driven by our forward-thinking leadership, we have built a strong culture of innovation and collaboration as well as a talented workforce committed to the success of our clients and each other. We are intentional about fostering an inclusive workplace where all employees are supported and given the tools to succeed. We are focused on recruiting and nurturing the next generation of exceptional legal talent and are proud that our recruitment and professional development efforts are recognized as among the best in the industry. Visit us at www.akingump.com or follow us on Twitter at @Akin_Gump.

Founded 1945